Tanya Cranfield

Real-world experience with caplacizumab in the management of acute TTP

Tina Dutt, Rebecca Shaw, Matthew Stubbs et al. · Blood · 2020 · 159 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +2

Presenting ADAMTS13 antibody and antigen levels predict prognosis in immune-mediated thrombotic thrombocytopenic purpura

Ferras Alwan, Chiara Vendramin, Karen Vanhoorelbeke et al. · Blood · 2017 · 126 citations · Full text

Medicine, Hematology, Pathology +12

Bortezomib in the treatment of refractory thrombotic thrombocytopenic purpura

Christopher J. Patriquin, Mari Thomas, Tina Dutt et al. · British Journal of Haematology · 2016 · 82 citations · Full text

Medicine, Hematology, Pharmacology +13

A British Society for Haematology Guideline: Diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies

Marie Scully, R. Rayment, Amanda Clark et al. · British Journal of Haematology · 2023 · 80 citations · Full text

Medicine, Hematology, Hematopathology +11

Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With <i>NPM1</i> and <i>FLT3</i> Mutations

Nigel H. Russell, Charlotte S. Wilhelm-Benartzi, Jad Othman et al. · Journal of Clinical Oncology · 2024 · 41 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15